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Abstract
The lasso peptide microcin J25 is known to hijack the siderophore receptor FhuA for initiating
internalization. Here, we provide the first structural evidence on the recognition mechanism and
our biochemical data show that another closely related lasso peptide cannot interact with FhuA.
Our work provides an explanation on the narrow activity spectrum of lasso peptides and opens the
path to the development of new antibacterials.
Under iron starvation, Gram-negative bacteria are capable of acquiring iron in the form of
ferric siderophore complexes that are taken up by high affinity outer membrane iron
receptors, such as FhuA, FepA, FecA and Cir in Escherichia coli. These receptors provide
an advantage for the cells to scavenge iron, but can also be exploited by antibacterial
compounds produced by other bacteria, or in infection by bacteriophages. Microcins form a
class of gene-encoded antibacterial peptides of low molecular weight (< 10 kDa) involved in
the defence strategies of Enterobacteriaceae for colonisation and survival 1. Several post-
translationally modified microcins exploit the iron uptake receptors of closely-related
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sensitive cells and kill them, through a TonB-dependent process 1. Microcin J25 (MccJ25) is
a 21-amino acid peptide characterized by a lasso topology. It contains an N-terminal
macrolactam ring (Gly1-Glu8) through which a C-terminal tail (Tyr9-Gly21) is threaded and
sterically locked by the bulky residues Phe19 and Tyr20 located below and above the ring,
respectively 2, 3 (Supplementary Results, Supplementary Fig. 1). MccJ25 exerts potent,
narrow spectrum antibacterial activity against Escherichia and Salmonella species through
inhibition of RNA polymerase 4. In E. coli, MccJ25 enters the target bacteria through the
outer membrane siderophore receptor FhuA 5 and inner membrane protein SbmA 6. We
have previously shown that MccJ25 can bind to FhuA with a KD of 1.2 μM 7.
The physiological role of FhuA is to transport Fe(III) chelated to the hydroxamate
siderophore ferrichrome to ensure iron uptake for bacterial growth. Fe(III) is highly
insoluble and poorly accessible in the environment and requires the formation of soluble
iron siderophore complexes, to be taken up by bacteria. FhuA is also the receptor for the
siderophore-conjugated antibiotic albomycin, a structural analogue of ferrichrome 8, the
rifamycin CGP 4832, which has no structural similarity with ferrichrome 9, the bacterial
toxin colicin M and phages T1, T5 and Φ80, which all hijack this receptor. Ferrichrome and
MccJ25 lack structural similarity, raising questions as to how MccJ25 hijacks the FhuA
receptor. Here, we provide the first structural evidence on the interaction of an antibacterial
lasso peptide with an outer membrane receptor. Using competition experiments with phage
T5 and ligand binding studies by non-denaturing mass spectrometry, we have identified a
key residue in MccJ25 that is important for recognition by FhuA. These data, combined with
modelling and biochemical experiments, lead to a proposal for how lasso peptides have
acquired their narrow spectrum of antibacterial activity.
We first determined the crystal structure of FhuA in complex with MccJ25 at 2.3 Å
resolution (Fig. 1a and Supplementary Table 1). The overall structure of FhuA is similar to
previously published structures 10, 11. FhuA is a monomeric β-barrel protein consisting of
22 antiparallel β-strands with its N-terminus folded inside the β-barrel from the periplasmic
side, thus forming the cork domain (residues 20-160) and a large extracellular ligand
binding pocket open to the external medium. Translocation of the ferrichrome requires
displacement of the ‘cork’. FhuA uses the proton motive force from the inner membrane
through the TonB/ExbB/ExbD complex to transport its substrates. The N-terminus of the
cork domain contains the switch helix, which harbours the TonB-box, a conserved seven-
amino acid sequence that has been shown to be important for interaction with TonB 12.
After molecular replacement and initial structure refinement, clear electron density was
observed for MccJ25 bound at the extracellular pocket of FhuA, detergent molecules and a
lipopolysaccharide (LPS) at the outer surface of the β-barrel (Fig. 1b and Supplementary
Fig. 2). The electron density allowed identifying the macrolactam ring (residues 1-8) of
MccJ25. Using the NMR structure of MccJ25 2, the macrolactam ring was placed in the
density without any manipulation. It sits vertically inside FhuA, whereas the β-hairpin loop
region (residues 9-18) shows significant conformational changes compared to the NMR
structure (Supplementary Fig. 3). In the NMR structure, the loop region forms two short β-
strands, whereas in complex with FhuA the loop has lost its β-strand structure and has
adopted a wider and less structured conformation. The FhuA-bound MccJ25 can be
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superimposed with the NMR structure with an rmsd of 2.3 Å over 21 Ca atoms and an rmsd
of 0.6 Å when aligned on the macrolactam ring. MccJ25 completely occupies and occludes
the FhuA channel. Residues from the FhuA β-barrel, the cork domain and extracellular
loops contribute to the binding of MccJ25 side chains and backbone (Supplementary Fig. 4).
Comparison of the MccJ25- and ferrichrome-bound FhuA structures show MccJ25 binds at
a very similar location to ferrichrome 10, 11 (Fig. 1c). Ferrichrome displays extensive
hydrogen bonds with the cork domain, whereas only two MccJ25 residues have hydrogen
bonds with this domain. The imidazole ring and backbone carbonyl group of His5MccJ25
make hydrogen bonds with the backbone carbonyl group of Phe115FhuA (2.8 Å) and side
chain of Tyr116FhuA (3.2 Å) respectively, whereas the backbone carbonyl group of
Ala3MccJ25 is within hydrogen bond distance from the side chain of Gln100FhuA (3.3 Å)
(Fig. 1d and Supplementary Fig. 4). The lack of extensive bonding between MccJ25 and the
cork domain indicates that minimal conserved interactions with the receptor are sufficient
for MccJ25 to hijack the binding pocket of FhuA. It has been proposed that binding of the
ligand to the extracellular pocket transmits allosteric changes along the cork domain 11.
Indeed, the imidazole ring of His5MccJ25 is “buried” further inside the cork domain relative
to the other residues. We investigated the role of the His5MccJ25 residue in competition
experiments with infection of E. coli cells by phage T5 7. Phage infection involves a strong
interaction of its receptor binding protein pb5 with FhuA 13 and release of its DNA. Phage
T5 infection therefore provides a functional assay to assess the binding of MccJ25 variants
to FhuA in vivo. In competition experiments with phage T5, the charge-conserved
MccJ25H5K variant showed slightly altered protection against phage infection compared to
MccJ25 (Fig. 2a, b), while the MccJ25H5A variant did not compete with phage (Fig. 2c). As
a second line of evidence, we performed ligand-binding studies by non-denaturing mass
spectrometry to calculate the affinity of MccJ25 and its variants for FhuA. This technique
was used to characterise the interaction of OmpF with bacteriocin colicin E9 14. The affinity
of MccJ25 for FhuA was calculated at 0.98 ± 0.02 μM, in agreement with our previously
published value of 1.2 μM determined by ITC 7 (Fig. 2d, Supplementary Fig. 5). The affinity
for the MccJ25H5K variant (16.9 ± 0.4 μM) is more than 10-fold decreased. Interestingly,
despite the absence of protection from phage T5 infection, the MccJ25H5A variant can still
bind to FhuA, although with much lower affinity (23.6 ± 0.8 μM). Different conformations
in the loop region could be acquired by the variants upon interaction with FhuA, which
could account for the lack of correlation between affinity of the variants and ability to
compete with T5. In addition, the distinct mechanisms of the MccJ25 antibacterial activity
and phage T5 infection could also account for the apparent inconsistency. However, taken
together, our data suggest that His5MccJ25 is essential for recognition and binding to the cork
domain of FhuA, and subsequently for transport. These results are further consistent with the
minimal inhibitory concentrations (MICs) measured for the peptides on E. coli W3110
(Supplementary Table 2). Interestingly, FhuA cannot efficiently transport the antibiotic
rifamycin, while it can transport the rifamycin derivative CGP 4832 15, which displays more
contacts with the cork domain 9. Indeed, CGP 4832 displays hydrogen bonds with the plug
domain residues Gly99FhuA (3.4 Å), Ser101FhuA (3.1 Å) and Tyr116FhuA (3.2 Å). Alignment
of the FhuA-MccJ25 structure with that of CGP 4832 reveals that His5MccJ25 is in the same
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position as the methyl-piperidine group of CGP 4832 (Supplementary Fig. 6), providing
further evidence on the ability of MccJ25 to contact the plug domain.
Previous knockout studies of the fhuA gene have confirmed the importance of FhuA for
internalization of MccJ25 inside the cell 6. Using a tonB minus strain we showed that
MccJ25 internalization is dependent on the FhuA-TonB system (Supplementary Fig. 7),
providing direct evidence that MccJ25 can induce displacement of the cork domain for
transport via the TonB-dependent pathway. Therefore, MccJ25 and the MccJ25H5K variant
could provide protection against T5 infection through the possible displacement of the cork
domain, since T5 cannot infect a cork-less FhuA 16, allowing another explanation for the
different activities of the MccJ25 variants. We have previously shown that the MccJ25 loop
is also essential for recognition by detergent-purified FhuA 7. This is consistent with the
absence of binding to FhuA (Supplementary Fig. 5, 8 and Supplementary Table 3) and
competition with phage T5 observed for the thermolysin-cleaved MccJ25 (t-MccJ25).
Finally, we investigated if recognition of MccJ25 by FhuA is independent on the lasso
topology of the macrolactam ring by using the cyclic-branched topoisomer (MccJ25-lcm),
which contains the macrolactam ring but not the lasso topology. We did not observe
protection against T5 infection or binding (Supplementary Fig. 5, 8 and Supplementary
Table 3). We conclude that the macrolactam ring itself cannot mediate binding of MccJ25 to
FhuA and that the integrity of the loop is also essential for binding.
Lasso antibacterial peptides usually display a very narrow spectrum of activity against
bacteria closely related to their producers. MccJ25 exerts its potent antibacterial activity
exclusively against Escherichia and some Salmonella species 17. Capistruin (Cap), which is
another lasso peptide produced by Burkholderia thailandensis, has a moderate antibacterial
activity directed against Burkholderia species 18, though its internalization process is not
known. Since both lasso peptides inhibit E. coli RNA polymerase with equal efficiency in
vitro 4, 19, it is likely that the narrow spectrum of activity is due to specific interaction of the
lasso peptides with the outer membrane receptors. The NMR structure of Cap, which has a
shorter loop and longer tail than MccJ25, could be modelled in the FhuA extracellular
pocket with some steric clashes (Supplementary Fig. 9) that could be relieved by
conformational changes of the C-terminal tail 18. However, Cap did not provide protection
against phage T5 (Supplementary Fig. 8), did not bind to E. coli FhuA (Fig. 2d) and did not
show antibacterial activity on E. coli W3110 at concentrations up to 100 μM
(Supplementary Table 2). Sequence analysis of FhuA receptors from Burkholderia and E.
coli show they share weak similarity (35% sequence identity) and the residues aligning the
extracellular pocket are not very well conserved (Supplementary Fig. 10). This suggests that
bacterial antimicrobial peptides have acquired structural features to target a very narrow
spectrum of related bacteria by complementing specific outer membrane receptor binding
pockets.
In conclusion, we have shown that MccJ25 can hijack the outer membrane siderophore
receptor FhuA by mimicking the binding mode of ferrichrome to induce TonB-dependent
transport. In addition, its narrow spectrum of antibacterial activity can be attributed to its
overall structure and specific interactions with the FhuA binding pocket and cork domain.
The emergence of resistant bacteria remains a critical problem and in the context of poor
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development of novel antimicrobial drugs, the possibility of developing antibiotics that
penetrate bacteria efficiently through high affinity iron-transport receptors is very
attractive 20. Internalization of siderophore-antibiotic conjugates such as albomycin is
strongly affected by modifications, while MccJ25 internalization and inhibitory properties
have been shown to accept a wide range of sequence modifications 21, 22. These sequence
variations could be mapped on the FhuA-MccJ25 complex to provide structural models for
the enhancement of MccJ25 uptake and activity (Supplementary Fig. 11). The antibacterial
activity of MccJ25 has been demonstrated both ex vivo, in complex fluid matrices, and in
vivo in a mouse model of infection by Salmonella 23, and without haemolytic activity on
human erythrocytes, thus suggesting a potential therapeutic role of this lasso peptide. The
unique and very stable lasso structure of MccJ25 makes it an ideal platform to be considered
for the design of novel molecules against bacterial infections and the structure of MccJ25 in
complex with FhuA will prove a valuable and helpful tool for such developments.
Online Methods
Protein expression and purification
FhuA from E. coli MG1655 was cloned with an internal His-tag and overexpressed as
previously described 24. Outer membranes from 10 L cell culture were prepared as in 25.
FhuA was extracted using 1 % lauryldimethylamine-oxide (LDAO) for 1 h at room
temperature in 1 × PBS. The solubilized suspension was spun at 120,000 g for 1 h to remove
unsolubilized material. Subsequent purification steps were performed at 4°C. The
supernatant was brought to 50 mM imidazole and was passed through a 5 mL His-Trap
column (GE Healthcare) equilibrated in 1 × PBS, 30 mM imidazole and 0.1 % LDAO. The
column was washed with 5 column volumes (CV) of equilibration buffer and with a further
5 CV of 1 × PBS, 50 mM imidazole and 0.1 % LDAO. FhuA was eluted in the same buffer
containing 300 mM imidazole. The eluted protein was concentrated using a 50 kDa cut-off
concentrator and injected in a Superdex S200 10/300 size exclusion column (GE Healthcare)
equilibrated in 50 mM ammonium acetate pH 8.0, 10 mM NaCl and 0.06% LDAO. The
fraction corresponding to FhuA was concentrated to 15 mg ml−1 for crystallization.
Peptides
MccJ25 was produced from a culture of E. coli K12 MC4100 harboring the plasmid
pTUC202, as described previously 26. The variants MccJ25[His5Ala] and [His5Lys] were
obtained by site-directed mutagenesis using the Quick-Change II XL kit (Agilent) 22. Cap
was produced from a culture of Burkholderia thailandensis E264, as previously
described 18. The peptide t-MccJ25 (MccJ25 hydrolyzed between Phe10 and Val11) was
obtained by incubation of MccJ25 in the presence of thermolysin. The purification of the
peptides was carried out by solid phase extraction followed by semi-preparative reverse-
phase-HPLC 22 (HPLC only for t-MccJ25). The purity and lasso topology of the peptides
were checked by liquid-chromatography – mass spectrometry, as previously reported 22
(Supplementary Fig. 12 and Supplementary Table 4). The synthetic cyclic branched peptide
MccJ25-lcm was obtained from Genepep (Saint Jean de Védas, France), with a purity >
95%.
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Inhibition of infection with phage T5
A 10 mL preculture of E. coli W3110 in LB medium was incubated for overnight at 37°C
and 250 rpm. 10 mL LB medium were inoculated with 200 μL preculture, and incubated at
37°C and 250 rpm until reaching an optical density at 600 nm of 1, corresponding to a viable
bacteria concentration of 5×108 c.f.u. (colony-forming units)/mL. 90 μL of the bacterial
suspension were deposited in a 96-well microplate, and 10 μL peptide were added (MccJ25
or MccJ25 variants or Cap dissolved in methanol/water 1:1), with a final peptide
concentration in the range 0.25-100 μM. A control was performed with 10 μL solvent added
to the bacterial suspension. 10 μL phage T5 in phage buffer (Tris/HCl 10 mM, pH 7.5, NaCl
150 mM, CaCl2 1 mM, MgSO4 1 mM) was added to every well, to reach a multiplicity of
infection (MOI) of 2.5. The microplate was incubated at 37°C under shaking in a
POLARstar OMEGA microplate reader (BMG Labtech), and bacterial growth and lysis
were monitored over 120 min by measurement of the optical density at 600 nm. A control
for bacterial growth was performed in the presence of peptide and in the absence of phage
T5 (Supplementary Fig. 8). Each experiment was made in triplicate.
Antibacterial activities
The MICs were measured using a liquid growth inhibition assay in poor broth (PB: 1%
bactotryptone, 0.5% NaCl w/v). 10 μL of serial dilutions of peptides (MccJ25,
MccJ25[His5Lys], MccJ25[His5Ala], Cap) were added to 90 μL of a mid-logarithmic
growth phase culture of E. coli W3110 diluted in PB to an optical density of 0.001 at 600
nm. Each peptide dilution was tested in triplicate. The plates were incubated at 37°C under
shaking in a POLARstar OMEGA microplate reader (BMG Labtech), and the bacterial
growth was monitored over 120 min by measurement of the optical density at 600 nm. The
MICs were determined as the lowest peptide concentrations showing complete inhibition of
the bacterial growth.
tonB antibacterial assay
E. coli W3110 tonB− strain was a kind gift from Prof. Lucienne Letellier (IBBMC, Orsay,
France). The antibacterial activity of MccJ25 towards E. coli W3110 wildtype and tonB−
strains was tested by a spot-on-lawn assay. Briefly, 107 E. coli cells were mixed with 3 mL
LB soft agar and plated onto a LB agar plate. After solidification, 10 μL MccJ25 in MeOH
(1-100 μg/mL) were spotted. A positive control using kanamycin was set up in parallel. The
plates were incubated at 37°C overnight.
Non-denaturing mass spectrometry
FhuA protein sample was buffer exchanged to 200 mM ammonium acetate supplemented
with 0.03% (w/w) LDAO detergent using Bio-Spin 6 (Bio-Rad) columns prior to mass
spectrometric analysis. The spectra were acquired on a QToF mass spectrometer (Waters)
previously modified for transmission of high masses and also modified for high energy in
collision cell 27, 28. Samples were introduced into the mass spectrometer from a gold coated
capillary needle using following conditions: capillary voltage 1.7 kV, cone voltage 200 V
and collision cell energy 320 V. Lowering the energy in collision cell gave rise to higher
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charge states of the protein possibly corresponding to unfolded population. Further decrease
resulted in an unresolved hump.
MccJ25 and variant peptides binding to FhuA
Non-denaturing electrospray titration experiments were performed using the MccJ25 and
variant peptides using FhuA at a constant concentration of 7.5 μM. Peptide were diluted to
100 μM concentration in 200 mM ammonium acetate in presence of 0.03% LDAO. For any
particular point titration, peptide was diluted from the stock solution to a concentration
double that required. The peptide was then added to FhuA solution at 1:1 / v:v ratio, to yield
the required concentration of the peptide. For Cap, Mccj25-lcm and t-MccJ25 only 20 μM of
each peptide was used (Supplementary Fig. 5).
Crystallization
Prior to crystallization, the protein (15 mg ml−1) was incubated with 1 mM MccJ25 at room
temperature overnight. Crystals were grown at 20°C using the vapour diffusion method by
mixing protein and reservoir solutions at 1:1. Crystals were grown from a precipitant
solution containing 20 mM Tris pH 7.5, 120 mM lithium sulfate, 100 mM sodium citrate pH
5, 20 % PEG300. The crystals grew after seven days and achieved maximum size after 2
weeks. The crystals were directly frozen into liquid nitrogen and diffraction screening and
data collection were performed at Diamond Light Source synchrotron. The crystals
diffracted X-rays to a maximum of 2.3 Å resolution.
Data collection
Diffraction data to 2.3 Å resolution were collected on I04-1 at Diamond Light Source at a
wavelength of 0.92 Å using a Pilatus 2M detector. Data were processed with xia2 29. The
resolution of the data and anisotropy analysis were evaluated by half-dataset correlation
coefficient in Aimless (cut-off less than 0.5) 30. The space group was determined to be
C2221 with one copy of FhuA in the asymmetric unit. The data collection statistics are
summarized in Supplementary Table 1.
Structure solution and refinement
The structure was solved by molecular replacement in Phaser 31 using the apo FhuA
structure (PDB ID: 2FCP) 10 as a search model. All model building was performed in Coot.
Initial rounds of refinement were carried out in Phenix 32 and later in Buster 33. After rigid
body and restrained refinement extra electron density corresponding to MccJ25 (Fig. 1b and
Supplementary Fig. 2), one molecule of lipopolysaccharide and several detergent molecules
were identified. In the PDB, there are two MccJ25 NMR structures deposited (PDB ID:
1Q71 2 and 1PP5 3) that are identical in structure. The NMR structure of MccJ25 with PDB
ID 1Q71 was used to build the microcin into the density. The high resolution of the electron
density maps, allowed us to identify the macrolactam ring and side chains of MccJ25, which
could fit in the density without any manipulation, whereas the loop region had undergone
conformational changes upon binding to FhuA (loss of β-hairpin loop). Water molecules
were added using ARP/wARP 34. The final FhuA structure contains residues 20-404 and
418-725. The electron density at the internal His-tag loop region was too weak/absent to
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allow building residues 405-417 reliably. The final model has an Rfactor of 21.2 % and an
Rfree of 25.5 %. The refinement statistics are summarized in Supplementary Table 1. The
FhuA structure has 96.3 % of the residues in the favoured Ramachandran region and 0.14 %
outliers as judged by MolProbity. The outlier corresponds to Gly566 in a loop turn.
Capistruin modelling
The NMR structure of Cap (Biological Magnetic Resonance Data Bank ID: 20014) 18 was
used for modelling into the FhuA receptor. The macrolactam ring of Cap was superposed
onto the MccJ25 macrolactam ring using the program Superpose in CCP4; the two
molecules aligned with an rmsd deviation of 1.74 Å over 8 Cα atoms. The loops could not
be aligned against each other due to significant differences in their length and conformation.
At the current orientation there are significant clashes between FhuA and the C-terminal tail
of Cap that can be relieved with manipulation of the overall conformation of the tail. The
current model satisfies some of the hydrophobic contacts and hydrogen bonds between
FhuA and Cap. Rotation of Cap by 90 °, 180 ° or flipping it along its axis results to a worst
model with clashes between the C-terminal tail and FhuA that cannot be relieved even after
manipulation.
The FhuA-MccJ25 coordinates and structure factors have been deposited to the Protein Data
Bank with PDB ID code 4cu4.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Structure of E. coli FhuA in complex with MccJ25. (a) MccJ25 (yellow sticks) binds to the
extracellular pocket of the outer membrane ferrichrome receptor FhuA. FhuA is displayed as
grey ribbons and the plug domain is shown in light blue. The front face of FhuA, detergent
molecules and LPS have been omitted for clarity. (b) Unambiguous 2Fo-Fc electron density
was observed for MccJ25 after molecular replacement and rigid body refinement. MccJ25
was not included in the refinement but is shown for clarity. The map is contoured at 1σ (see
also Supplementary Fig. 2). (c) MccJ25 (yellow sticks) mimics the binding of the
ferrichrome (red sticks; iron is shown as an orange sphere). (d) MccJ25 displays three
hydrogen bonds with the plug domain. Other interactions are shown in Supplementary Fig.
4. MccJ25 carbons are shown as yellow sticks, oxygens in red and nitrogen in blue. The
FhuA plug domain side chains carbons are in light blue. The rest of the atoms are as in
MccJ25.
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Interaction studies of lasso peptides with FhuA by phage T5 infection and non-denaturing
mass spectrometry. (a-c) E. coli W3110 was incubated with MccJ25 (a), MccJ25H5K (b),
and MccJ25H5A (c) at concentrations of 1 or 10 μM, or with solvent only. After addition of
phage T5, lysis was monitored by measuring culture turbidity (OD 600 nm) for 120 min.
The data shown are the average of three measurements for each condition. (d) Non-
denaturing mass spectra showing binding of MccJ25, MccJ25H5K and MccJ25H5A to FhuA.
Increasing concentrations of the peptides were titrated to FhuA (Supplementary Fig. 5).
Only the 7.5 μM peptide concentration of the MccJ25 and its variants are shown. Cap is
shown at 20 μM peptide concentration. Each mass spectrum and mass-to-charge peak is
assigned according to incubation condition. In the mass spectra we observed higher
molecular weight species with low intensity that probably corresponded to non-specific
binding of a second peptide at highest concentration; a second binding molecule was also
observed from the ITC data 7.
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